Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of the hemicholinium-3 analog,
DMAE
, on endplate currents (EPC) was investigated in the transected cutaneous pectoris muscle of the frog using a conventional two-microelectrode voltage clamp. At a low concentration (5 microM),
DMAE
produced a long-lasting decrease in the rate constant of decay (alpha) and an increase in the peak current amplitude (Ip). At higher concentrations (10--100 microM),
DMAE
produced biphasic changes characterized by a transient, marked decrease of alpha and increase of Ip followed by a long-lasting marked increase of alpha and decrease of Ip. When
DMAE
was removed from the bath recovery from block was
asymmetrical
in that alpha recovered more quickly than did Ip. Pretreatment with neostigmine or collagenase partially antagonized the initial effects without affecting the steady state effects of
DMAE
, indicating that the initial effects of
DMAE
may be, at least in part, due to inhibition of the enzyme acetylcholinesterase. The drug reverses the normal voltage dependence of alpha without altering the single exponential nature of decay of the EPC. The inward EPC was more markedly blocked than outward EPC, resulting in a highly non-linear current-voltage relation with Ip decreasing with increasing hyperpolarization. This effect may indicate that
DMAE
causes a voltage-dependent block of closed acetylcholine-activated ion channels.
...
PMID:Endplate channel actions of a hemicholinium-3 analog, DMAE. 301 71